Concept of a point of care test to detect new oral anticoagulants in urine samples

New oral anticoagulants (NOAC) are approved for several indications for prophylaxis and treatment of venous thromboembolism and for prevention of embolism in atrial fibrillation at fixed daily doses without need of laboratory guided dose adjustment. Due to their low molecular weight of about 500 to...

Descripción completa

Detalles Bibliográficos
Autores principales: Harenberg, Job, Krämer, Sandra, Du, Shanshan, Weiss, Christel, Krämer, Roland
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3766639/
https://www.ncbi.nlm.nih.gov/pubmed/23915217
http://dx.doi.org/10.1186/1477-9560-11-15

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3766639/
https://www.ncbi.nlm.nih.gov/pubmed/23915217
http://dx.doi.org/10.1186/1477-9560-11-15

Ejemplares similares